Skip to main content
TipRanks
Go Ultimate75% OFF

CNO Financial (COS) Q3 2026 Earnings Report

1 Followers

DE:COS Q3 2026 EPS Results

Actual EPS
EUR 1.69
Consensus EPS
EUR 0.98
Beat/Miss
Beat by +EUR 0.72
One Year Ago EPS
EUR 1.15

DE:COS Q3 2026 Revenue Results

Actual Revenue
EUR 994.46M
Expected Revenue
EUR 899.11M
Beat/Miss
Beat by +EUR 95.35M
YoY Revenue Growth
-7.19%

Earnings Announcement Details

Quarter
Q3 2026
Date
10/29/2026
Time
After Close
Conference Call
Thursday, October 29, 2026
DE:COS Upcoming Earnings

CNO Financial's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:COS Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Oct 29, 2026|% Change Since:6.40%|
Earnings Call Sentiment|Positive

The call was strongly positive. CNO reported substantial earnings growth, consecutive periods of sales and agent-count growth, improving expense leverage, strong investment income, robust capital levels, and raised full-year earnings guidance. The company also highlighted strong Medicare Supplement, Worksite and asset accumulation momentum. Offsetting issues included declines in reported Life NAP, unfavorable Medicare Supplement morbidity, Medicare Advantage market disruption, nonrecurring investment income outperformance, and capital consumption from investments, but management characterized demand and the overall operating outlook as resilient.

Company Guidance

For 2026, CNO raised operating earnings per share guidance to a range of between $5.05 to $5.15, representing a 9% increase at the midpoint from prior guidance, with an expense ratio of 18.6% to 18.8%, an operating effective tax rate of approximately 20.5%, full year fee income of approximately $25 million, and free cash flow of between $220 million and $240 million; there is no change to the target RBC ratio, minimum holdco, holding company liquidity or leverage ranges, and 2026 operating return on equity is clearly on track to exceed the 12% target previously established for year-end 2027. The company expects roughly $70 million of TechMod cash spend for the full year and a comparable amount in 2027, expects to establish new long-term targets in February of next year, and said the current expense ratio is sustainable with some room for improvement going forward.

  • Operating Earnings Delivered Strong GrowthThird-quarter operating earnings per diluted share were $1.90, up 47% year over year, while operating earnings per diluted share excluding significant items were $1.42, up 48%. Year-to-date operating earnings per diluted share were up 43%, or 45% excluding significant items.
  • Full-Year Earnings Guidance RaisedThe company raised 2026 operating earnings per share guidance to $5.05-$5.15, representing a 9% increase at the midpoint from prior guidance. The updated outlook includes an expense ratio of 18.6%-18.8%, down from 18.8%-19.0%, an operating effective tax rate of approximately 20.5% versus the prior estimate of 21.5%, and full-year fee income of approximately $25 million.
  • Consistent Sales and Distribution GrowthCNO delivered its 17th consecutive quarter of sales growth and 15th consecutive quarter of producing agent count growth. Producing agent count increased 4%, and nearly all growth scorecard metrics were up for the quarter.
  • Consumer Division Sustained Growth Across Key ProductsThe Consumer Division delivered its 16th consecutive quarter of sustained sales growth, supported by continued strength in health, annuities, brokerage and advisory, as well as strong agent productivity and retention.
  • Medicare Supplement MomentumTotal Health NAP increased 7%, marking 17 consecutive quarters of growth. Medicare Supplement NAP increased 41% in the quarter and more than 60% over the last 12 months. Total Medicare policies sold, including Medicare Advantage, increased 20%.
  • Life Production Excluding Discontinued Pilot IncreasedAlthough reported Life NAP declined 9% against a strong prior-year comparison that included $13 million of NAP from a discontinued third-party pilot program, Life NAP increased 20% excluding that production. Direct-to-consumer NAP increased 29%.
  • Direct-to-Consumer Channel DiversificationNon-television marketing channels, including web, digital and third-party partners, generated 71% of all direct-to-consumer life sales. The company said it continues to invest selectively in productive opportunities and experiment with third-party partners using limited upfront investment.
  • Asset Accumulation GrowthAnnuity collected premiums totaled $514 million, up 9%, and annuity account values increased 7%. Brokerage and advisory delivered its 14th consecutive quarter of growth, with client assets up 15% to a new record, total accounts up 13%, and registered agent count up 4%. Across annuity account values and brokerage and advisory, clients entrusted CNO with nearly $20 billion of assets, up 9%.
  • Worksite Division Delivered Double-Digit GrowthThe Worksite Division produced its 18th consecutive quarter of sustained sales growth. Life and Health NAP increased 18%, marking the eighth consecutive quarter of double-digit sales growth. Producing agent count reached a record level, up 6%, and Worksite career field agent NAP increased 29%.
  • Strong Worksite Product and New-Client PerformanceWorksite life sales increased 59%, while hospital indemnity and accident sales each increased 16%. NAP from new clients increased 168%, balanced between geographic expansion and deeper penetration of existing markets.
  • Improved Operating Leverage and Expense RatioThe trailing-12-month expense ratio was 18.5%, a 50-basis-point improvement from the prior year. Management attributed the improvement to expenses running below expectations and higher revenues from strong sales growth, and said the current expense ratio is sustainable with additional opportunity for improvement through better operating leverage.
  • Insurance Product Margin ImprovedTotal insurance product margin excluding significant items increased 7%, primarily reflecting the compounding benefit of sustained sales momentum. Favorable contributions included growth in fixed indexed annuities, favorable reserve releases on certain closed-block annuity policies, growth in supplemental health and long-term care, and lower mortality in interest-sensitive life.
  • Favorable Annual Actuarial ReviewThe annual actuarial review had a $56.3 million favorable impact on operating income, reflecting broad-based favorable experience across the product portfolio, led by traditional life, fixed indexed annuities, supplemental health and long-term care.
  • Net Investment Income Continued to GrowTotal net investment income increased 13% year over year, marking the 12th consecutive quarter of growth. Net investment income allocated to product lines increased 4%, while net investment income not allocated to products increased 72%, primarily due to favorable alternative investment income.
  • Attractive Investment Yields and Portfolio QualityThe new money rate was 6.24%, marking the 15th consecutive quarter above 6%. New money rates have exceeded 6% for 15 consecutive quarters while maintaining a high-quality portfolio, and book yield increased 9 basis points year over year.
  • Robust Capital Position and Shareholder ReturnsAll capital and liquidity metrics remained within or above target levels. CNO returned $77 million to shareholders, including $60 million of excess capital deployed to share repurchases, which contributed to a 4% reduction in weighted average diluted shares outstanding. Book value per diluted share excluding AOCI was $41.29, up 8%.
  • Improving Return on EquityTrailing-12-month operating return on equity was 15.4%, or 14.1% excluding significant items. Management said 2026 operating return on equity is on track to exceed the 12% target previously established for year-end 2027 and remains focused on achieving top-quartile peer performance.
  • Third Bermuda Reinsurance Treaty CompletedEffective October 1, CNO ceded approximately $270 million of U.S. statutory graded benefit life reserves from Colonial Penn Life Insurance Company to CNO Bermuda Re. Management said the transaction creates greater liability diversification and opportunities to optimize assets and capital, and that the Bermuda operation is an important component of capital deployment.
  • Private Credit and Asset-Based Finance Portfolio ExpansionCNO has approximately $2 billion of private credit, including asset-based finance at about half, direct lending at about 20% and portfolio finance at about 20%. Management said the asset-based finance portfolio is higher-rated investment grade, primarily backed by structured consumer credit, and offers excess spread, credit support, short duration and attractive earnings.
  • Technology Modernization Investment ContinuesThe company is investing in technology modernization, with cash spending of approximately $45 million through September 2026 and roughly $70 million expected for the full year. Management expects a comparable amount of spending in 2027.
  • Resilient Demand OutlookManagement said it is not seeing anything that indicates a material reduction in demand for its services. It cited people turning 65, limited employer and government coverage for relevant exposures, and a lack of credible alternatives as factors supporting relatively robust demand.

DE:COS Earnings History

DE:COS earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 09, 20272026 (Q4)1.21-1.31――
Oct 29, 20262026 (Q3)0.981.691.1547.29% (+0.54)
Jul 30, 20262026 (Q2)0.871.120.7844.83% (+0.35)
Apr 30, 20262026 (Q1)0.840.940.732.91% (+0.23)
Feb 05, 20262025 (Q4)1.071.311.1712.21% (+0.14)
Nov 03, 20252025 (Q3)0.821.150.9916.22% (+0.16)
Jul 28, 20252025 (Q2)0.760.780.94-17.14% (-0.16)
Apr 28, 20252025 (Q1)0.700.700.4651.92% (+0.24)
Feb 06, 20252024 (Q4)0.951.171.0511.02% (+0.12)
Oct 31, 20242024 (Q3)0.730.990.7926.14% (+0.21)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed